Sucroferric oxyhydroxide Guanules Questionnaire survey

Sucroferric oxyhydroxide Guanules Questionnaire survey - Sucroferric oxyhydroxide Guanules Questionnaire survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034904

Enrollment

Registered

2018-11-20

Start date

2018-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of hyperphosphatemia in dialysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Administered Sucroferric oxyhydroxide Guanules and hyperphosphatemia in dialysis patients 2)Patients can acquire written informed consent appropriately (excluding patients with dementia)

Exclusion criteria

Exclusion criteria: Pharmacist judged ineligible as subject of investigation

Design outcomes

Primary

Measure	Time frame
Administration feeling	—

Countries

Japan

Contacts

Public ContactYoshinobu Oikawa

APO PLUS STATION CO., LTD. CRO Division

y-oikawa@apoplus.co.jp03-6386-9500

Outcome results